Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by abnormal myocardial hypertrophy, which can lead to a wide clinical spectrum, including sudden cardiac death and heart failure.

A recent study validated new thresholds for left ventricular hypertrophy to improve both HCM diagnosis and timely treatment ...

The study links exertional heat stroke to chronic disorders, revealing impacts on body mass regulation and heart health, ...

STATEN ISLAND, N.Y. — Northwell Staten Island University Hospital (SIUH) has introduced a new program for the diagnosis and ...

New therapies to blunt this process include targeting enzymes below the cell membrane that serve as strategic nodes for hypertrophy regulation. Rho kinase (ROCK) is activated in cardiac ...

Another active area of research in the laboratory focuses on unraveling the mechanisms behind maladaptive, or pathological, and adaptive, or physiological, cardiac hypertrophy. In response to certain ...

A 36-year-old man died last fall at the Spokane County Jail from a heart problem, according to the Spokane County Medical ...

Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular ...

HCM is typically characterized by asymmetric myocardial hypertrophy, which is often associated with diastolic dysfunction, LV outflow tract obstruction and mitral regurgitation. Myocardial cell ...